Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 12 (Search time: 0.006 seconds).
Item hits:
Issue DateTitleAuthor(s)
2020Did India’s price control policy for coronary stents create unintended consequences?Deo, Sarang; Tyagi, Hanu; Chatterjee, Chirantan; Molakapuri, Himasagar
12-Sep-2020Unpacking the effects of adverse regulatory events: Evidence from pharmaceutical relabelingHiggins, Matthew J.; Yan, Xin; Chatterjee, Chirantan
19-Jul-2021Intellectual property regimes and wage inequalityBhattacharya, Sourav; Chakraborty, Pavel; Chatterjee, Chirantan
9-Feb-2021How does regulation impact strategic repositioning by firms across submarkets? evidence from the Indian pharmaceutical industryBhaskarabhatla, Ajay; Anurag, Priyatam; Chatterjee, Chirantan; Pennings, Enrico
25-Feb-2021Women’s disempowerment and preferences for skin lightening products that reinforce Colorism: experimental evidence from IndiaAdbi, Arzi; Chatterjee, Chirantan; Clarissa, Cortland; Kinias, Zoe; Singh, Jasjit
12-Jul-2022Pandemics and technology engagement: new evidence from m-Health intervention during COVID-19 in IndiaRathi, Sawan; Chakrabarti, Anindya S.; Chatterjee, Chirantan; Hegde, Aparna
1-Dec-2022Generic competition and the incentives for early-stage pharmaceutical innovationBranstetter, Lee; Chatterjee, Chirantan; Higgins, Matthew J.
2-Feb-2023Movies, stigma and choice: evidence from the pharmaceutical industryAggarwal, Mayank; Chakrabarti, Anindya S.; Chatterjee, Chirantan
7-Nov-2022Cross-border environmental regulation and firm labor demandChakraborty, Pavel; Chakrabarti, Anindya S.; Chatterjee, Chirantan
23-Mar-2022How do MNEs and domestic firms respond locally to a global demand shock? evidence from a pandemicChatterjee, Chirantan; Adbi, Arzi; Mishra, Anant